InMed Pharmaceuticals Inc.·4

Dec 19, 11:41 AM ET

WOUDENBERG MICHAEL 4

4 · InMed Pharmaceuticals Inc. · Filed Dec 19, 2025

Insider Transaction Report

Form 4
Period: 2025-12-19
WOUDENBERG MICHAEL
VP, Chem/Manufacturing/Control
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-12-19+18,00025,445 total
    Exercise: $1.29Exp: 2030-12-18Common shares (18,000 underlying)
Footnotes (1)
  • [F1]The options were granted on 12/19/2025 and will vest in equal installments monthly, in arrears, over 36 months (1/36 per month)

Documents

1 file
  • 4
    ownership.xmlPrimary